195 related articles for article (PubMed ID: 7607270)
1. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
Pujol P; Bringer J; Faurous P; Jaffiol C
Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270
[TBL] [Abstract][Full Text] [Related]
2. [Nuclear medical therapy of pheochromocytoma].
Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].
Okazawa H; Endo K; Saga T; Watanabe Y; Nakai T; Kasagi K; Konishi J; Abe M; Goto K; Nakao K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):286-94. PubMed ID: 2345700
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear medicine diagnosis and therapy of distant metastases of pheochromocytoma].
Grünwald F; Ruhlmann J; Kozak B; Overlack A; Christ F; Hotze A; Biersack HJ
Dtsch Med Wochenschr; 1988 Feb; 113(8):297-9. PubMed ID: 3277832
[TBL] [Abstract][Full Text] [Related]
5. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
[TBL] [Abstract][Full Text] [Related]
6. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
[TBL] [Abstract][Full Text] [Related]
7. Results of [131I]metaiodobenzylguanidine treatment in metastatic malignant phaeochromocytoma.
Bestagno M; Pizzocaro C; Maira G; Terzi A; Panarotto MB; Guerra P
J Nucl Biol Med (1991); 1991; 35(4):277-9. PubMed ID: 1823835
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of phaeochromocytoma with 131I-metaiodobenzylguanidine.
Fischer M; Vetter W; Winterberg B; Zidek W; Hengstmann J; Vetter H
J Hypertens Suppl; 1984 Dec; 2(3):S187-9. PubMed ID: 6599667
[TBL] [Abstract][Full Text] [Related]
9. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
[TBL] [Abstract][Full Text] [Related]
10. [Radionuclide therapy of Sipple syndrome using iodine-131 metaiodobenzylguanidine].
Furusawa M; Shimomura O; Tomiguchi S; Hirota Y; Takahashi M; Yamauchi J; Iwaoka D; Satoh T
Kaku Igaku; 1992 Sep; 29(9):1133-8. PubMed ID: 1360550
[TBL] [Abstract][Full Text] [Related]
11. Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytoma.
Lewington VJ; Zivanovic MA; Tristam M; McEwan AJ; Ackery DM
J Nucl Biol Med (1991); 1991; 35(4):280-3. PubMed ID: 1823836
[TBL] [Abstract][Full Text] [Related]
12. 131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma.
Gedik GK; Hoefnagel CA; Bais E; Olmos RA
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):725-33. PubMed ID: 18071700
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up].
Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T
Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648
[TBL] [Abstract][Full Text] [Related]
14. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
Schvartz C; Gibold C; Vuillemin B; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
[TBL] [Abstract][Full Text] [Related]
15. Complete remission of metastatic pheochromocytoma in
Sugino T; Ando R; Unno R; Iida K; Naiki T; Hamamoto S; Mizuno K; Okada A; Umemoto Y; Kawai N; Tozawa K; Hayashi Y; Inaki A; Kayano D; Kinuya S; Yasui T
BMC Res Notes; 2017 Dec; 10(1):750. PubMed ID: 29258609
[TBL] [Abstract][Full Text] [Related]
16. A case of malignant pheochromocytoma treated by 131I-metaiodobenzylguanidine.
Theilade K; Bak M; Olsen K; Nielsen SL; Christensen NJ
Acta Oncol; 1988; 27(3):296-7. PubMed ID: 3415861
[No Abstract] [Full Text] [Related]
17. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
Nakabeppu Y; Nakajo M
Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
[TBL] [Abstract][Full Text] [Related]
19. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
[TBL] [Abstract][Full Text] [Related]
20. Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.
Blake GM; Lewington VJ; Fleming JS; Zivanovic MA; Ackery DM
Eur J Nucl Med; 1988; 14(7-8):345-8. PubMed ID: 3181183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
